Editorial draft — not for publication yet. Alprazolam content needs clinical and legal review before publication. This page is general information and is not advice about an individual prescription.

In short

Rlam-1 is a label associated with tablets described as alprazolam, but a label is not proof of a tablet’s ingredients or strength. An HSE alert reported that specific Rlam-1 tablets in Ireland contained tramadol rather than the alprazolam stated on the label. That alert does not establish what is in every pack. Do not take an unverified tablet; if someone has taken one and is unwell, seek urgent medical help.

For the general active-ingredient guide, continue to Alprazolam medicine guide. This page covers Rlam-1-specific product questions.

Rlam-1 UK product status

The available sources identify Rlam-1 as packaging or a label claiming alprazolam, not as a reliably verified UK product. An HSE drug-trend alert dated 17 December 2024 reported that specific Rlam-1 “Red backs” samples contained tramadol rather than labelled alprazolam; a Northern Ireland threat assessment separately pictured seized packaging labelled “Rlam-1 / Alprazolam Tablets I.P. 1mg”. Neither source authenticates all products sold under that name or establishes the contents of an individual tablet. We could not verify a UK-authorised product under this exact name from the sources reviewed; check the current MHRA database or ask a UK pharmacist. A label, photograph or claimed strength is not a safe way to identify a medicine.

What can be confirmed about Rlam-1?

Rlam-1 is a name printed on some tablets described as alprazolam. This page is about identifying that claim and the safety uncertainty around it—not a confirmation that Rlam-1 is a genuine, consistent or UK-authorised alprazolam medicine.

  • Some packaging and seizure reporting describe Rlam-1 as alprazolam; this documents a label claim, not a laboratory-confirmed ingredient for every pack.
  • An HSE alert reported tramadol in specific Rlam-1 tablets that were labelled as alprazolam. Do not generalise that result to every Rlam-labelled tablet or assume another pack is safe.
  • The name, colour, imprint, packaging and claimed strength cannot confirm a tablet’s identity, contents or dose.
  • If you are seeking information about prescribed alprazolam, use the separate UK alprazolam guide and the leaflet for the exact medicine dispensed to you.

A medicine’s name on a pack, its active ingredient, UK marketing authorisation, controlled-drug classification and a clinician’s decision to prescribe it are separate questions.

Do not use this page to identify a pill, choose a dose, or decide whether an unverified tablet is safe. A pharmacist or poison-information/urgent-care professional needs the exact circumstances.

This is a high-risk medicine topic. A UK clinician, toxicology-informed reviewer and regulatory reviewer must check this draft before publication.

How does it work?

If a tablet genuinely contains alprazolam, alprazolam is a benzodiazepine that enhances GABA-related inhibitory signalling in the central nervous system and can cause calming and sedating effects. That description must not be applied to an unverified Rlam tablet: reported samples have contained a different drug, and another sample could contain something else. Never infer effects, onset or duration from a label.

Risks and possible effects

If the tablet contains alprazolam

Prescribed alprazolam can cause sleepiness, slowed reactions, impaired coordination and memory problems. These are not a reliable prediction of the effects of an unverified Rlam tablet because its ingredients may differ.

Possible opioid exposure or poisoning

Some Rlam-1 samples reported by HSE contained tramadol, an opioid, rather than the labelled alprazolam. Call 999 if someone is hard to wake, collapses, has slow or difficult breathing, has a seizure or becomes unresponsive. Do not wait for symptoms to worsen.

Safety information

  • Do not take a tablet whose contents and source cannot be verified. Do not rely on the name, colour, stamp, photograph, seller claim or a claimed “1 mg” strength.
  • Do not combine an unknown tablet with alcohol, opioids, benzodiazepines, sleeping tablets, pregabalin or other sedating drugs. Combinations can cause profound sedation and life-threatening breathing problems.
  • If someone has swallowed an unknown tablet, contact NHS 111 promptly for advice even if they feel well; call 999 for severe symptoms. Keep the packaging and tell clinicians what is known without delaying help.
  • If a clinician has prescribed you a verified alprazolam medicine and you have taken it regularly, do not stop it abruptly without prescriber advice; withdrawal planning is different from the immediate advice not to take an unknown tablet.
  • Never drive, cycle or operate machinery after taking an unknown tablet or whenever sleepy, dizzy, confused or impaired.

What the available Rlam-1 reports do—and do not—show

An HSE drug-trend alert dated 17 December 2024 reported that Rlam-1 tablets known as “Red backs” had been found to contain tramadol, not alprazolam as labelled. The alert warns that packets can look alike while containing different substances. It concerns reported tablets and does not prove that every Rlam-1 tablet contains tramadol.

A Northern Ireland Organised Crime Task Force threat assessment shows seized packages labelled “Rlam-1 / Alprazolam Tablets I.P. 1mg”. This confirms that packaging with that wording was documented in a seizure; it is not a laboratory certificate that verifies the contents, maker, strength or quality of all products sold under the name.

Rlam-1 UK status is not the same as alprazolam status

UK product information exists for specific alprazolam tablets such as Xanax 250 and 500 microgram tablets. Those records describe those named products only. They do not establish that Rlam-1 is authorised, supplied by a UK pharmacy or equivalent to a licensed tablet. Search the MHRA product database for the exact product or ask a pharmacist to check it.

Government guidance lists alprazolam as a Class C, Schedule 4 Part I controlled drug. Controlled-drug status applies to the substance in law; it cannot identify the contents of a pill from its packaging. Legal rules and travel questions can depend on the UK nation and circumstances.

If you have a tablet labelled Rlam-1

Do not take it or give it to someone else. Keep it away from children and pets, do not crush or handle it unnecessarily, and ask a pharmacist or local medicines-return service how to dispose of an unknown tablet safely. Do not take it to a pharmacy loose if local guidance says otherwise; call first and explain what it is labelled as.

If anyone has already taken it, do not try to identify it by taste, appearance or taking a small amount. Contact NHS 111 for urgent advice. Call 999 for difficulty waking, breathing problems, collapse, seizure or severe confusion. Keep the packaging available and tell clinicians that the product may not match its label.

Anxiety or sleep searches: do not self-treat with Rlam-1

A search result or package claim that a product contains alprazolam does not make it an appropriate anxiety or sleep treatment. NICE says benzodiazepines for generalised anxiety disorder should generally be limited to a short-term measure during a crisis and advises against benzodiazepines for panic disorder because of poorer long-term outcomes.

For anxiety or insomnia, contact a GP, pharmacist or NHS 111 for advice about assessed, regulated care. Do not take an unverified tablet to try to calm down or sleep. If a verified prescribed alprazolam product is involved, follow that exact prescription and leaflet and speak to the prescriber about risks and the review plan.

Frequently asked questions

What is Rlam-1?

Rlam-1 is a name on tablets described as alprazolam. The label does not verify what is in a particular tablet; HSE reported that specific Rlam-1 samples contained tramadol instead.

Is Rlam-1 definitely alprazolam?

No. A package claim cannot confirm a tablet’s contents. HSE reported specific Rlam-1 tablets containing tramadol rather than labelled alprazolam. Do not assume another tablet has the same composition.

Is Rlam-1 a UK-authorised medicine?

The sources reviewed do not verify a UK-authorised medicine under the exact name Rlam-1. Check the exact product in the MHRA database or with a UK pharmacist; a UK alprazolam record for a different brand is not proof.

What should I do if I took a Rlam-1 tablet?

Contact NHS 111 promptly for advice, even if you currently feel well. Call 999 if you are difficult to wake, have slow or difficult breathing, collapse, have a seizure or become unresponsive. Keep the packaging for clinicians.

Can Rlam-1 help with anxiety or sleep?

Do not use an unverified tablet for anxiety or sleep. A label cannot establish the contents, and NICE limits benzodiazepine use for anxiety. Ask a UK healthcare professional about safe, regulated treatment.

Explore the detailed rlam-1 (labelled as alprazolam) guides

Each guide answers a different practical question. Advice is specific to alprazolam and should be checked against your own product leaflet and prescription.

Sources and review

This draft was checked against the sources below on 3 October 2026. It still requires clinical and legal review before publication.

Editorial status: Editorial draft — clinical, toxicology and regulatory review required before publication.